top of page
Profile
Join date: Jun 10, 2025
Posts (5)
Aug 13, 2025 ∙ 11 min
The Strategic Imperative: Leveraging Market Modeling for Valuation, Fundraising, and Growth in Life Sciences Innovation
Executive Summary The life sciences sector operates at the unique intersection of profound scientific innovation and extreme commercial...
16
0
Aug 11, 2025 ∙ 3 min
Defining the Addressable Market: The Foundation for a Credible Market Model
Accurately determining the addressable market for life sciences innovations is a foundational exercise, critical for strategic planning,...
10
0
Aug 4, 2025 ∙ 25 min
Physician Risk Tolerance and Novel Medical Technology Adoption: A Specialty-Specific Analysis
Predicting adoption of novel medical technologies is a complex process. One of the deciding factors as to "how far" and how fast a technology is adopted is influenced by the perceived risk by the potential adopter.
Risk tolerance differs among various medical specialties. This article describes how risk tolerance impacts the propensity to adopt novel medical technologies and the implications for technology developers, healthcare leaders & policy makers, and medical education.
37
0
Michael Kubica
Admin
More actions
bottom of page
